Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2553-2558

  Raimondo, Massimo ^a   Tachibana, Issei ^a   Urrutia, Raul ^a   Burgart, Lawrence J ^a   DiMagno, Eugene P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MALE; MUTATION; ONCOGENE K RAS; PANCREAS TUMOR; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CODON; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036790636     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04380-0     Document Type: Article

References (26)

1. Ohashi K, Murakimi Y, Maruyama M, et al. Four cases of mucous secreting pancreatic cancer (in Japanese). Prog Dig Endosc 1982;20:348-51.
2. Procacci C, Graziani R, Bicego E, et al. Intraductal mucinproducing tumors of the pancreas: Imaging findings. Radiology 1996;198:249-57.
3. Cellier C, Cuillerier E, Palazzo L, et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long-term outcome in a large surgical series. Gastrointest Endosc 1998;47:42-9.
4. Sugiyama M, Atomi Y, Saito M. Intraductal papillary tumors of the pancreas: Evaluation with endoscopic ultrasonography. Gastrointest Endosc 1998;48:164-71.
5. Nickl NJ, Lawson JM, Cotton PB. Mucinous pancreatic tumors: ERCP findings. Gastrointest Endosc 1991;37:133-8.
6. Sugiyama M, Atomi Y, Hachiya J. Intraductal papillary tumors of the pancreas: Evaluation with magnetic resonance cholangiopancreatography. Am J Gastroenterol 1998;93:156-9.
7. Loftus EV Jr, Olivares-Pakzad BA, Batts KP, et al. Intraductal papillary mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Gastroenterology 1996;110:1909-18.
8. Sessa F, Solcia E, Capella C, et al. Intraductal papillarymucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994;425:357-67.
9. Kondo H, Sugano K, Fukayama N, et al. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas. Cancer 1997;79:900-5.
10. Siech M, Tripp K, Schmidt-Rohlfing B, et al. Intraductal papillary mucinous tumors of the pancreas. Am J Surg 1999;177:117-20.
11. Karlson BM, Ekbom A, Josefsson S, et al. The risk of pancreatic cancer following pancreatitis: An association due to confounding? Gastroenterology 1997;113:587-92.
12. Niederau C, Luthen R. Alcohol and pancreatic diseases. Zeitschr Gastroenterol 1988;26(suppl 3):60-74.
13. Velema JP, Walker AM, Gold EB. Alcohol and pancreatic cancer. Insufficient epidemiologic evidence for a causal relationship. Epidemiol Rev 1986;8:28-41.
14. Fraumeni JF Jr. Cancers of the pancreas and biliary tract: Epidemiological considerations. Cancer Res 1975;35:3437-46.
15. Mulligan NJ, Yang S, Andry C, et al. The role of p21ras in pancreatic neoplasia and chronic pancreatitis. Hum Pathol 1999;30:602-10.
16. Z'graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumor of the pancreas. Ann Surg 1997;226:491-500.
17. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucus cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
18. Van Laetham V, Bourgeois M, Delhaye J, et al. K-ras mutations in patients with chronic pancreatitis. High prevalence but undetermined relevance. Gastroenterology 1997;A490:112 (abstract).
19. Fujii H, Inagaki M, Kasai S, et al. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 1997;151:1447-54.
20. Miyamoto Y, Hosotani R, Wada M, et al. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 1999;56:73-82.
21. Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999;94:470-3.
22. Jiang ZL, Satoh K, Moriizumi S, et al. An analysis of the diseases associated with mucin-producing tumors of the pancreas. J Jpn Pancreas Soc 1996;11:289-292. (in Japanese).
23. Madura JA, Wiebke EA, Howard TJ, et al. Mucin-hypersecreting intraductal neoplasm of the pancreas: A precursor to cystic pancreatic malignancies. Surgery 1997;122:786-93.
24. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas. Imaging studies and treatment strategies. Ann Surg 1998;228:685-91.
25. Traverso WL, Peralta EA, Ryan JA Jr, Kozarek RA. Intraductal neoplasms of the pancreas. Am J Surg 1998;175:426-32.
26. Azar C, Van de Stadt J, Ricaert F, et al. Intraductal papillary mucinous tumors of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39:457-64.